The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
The oncogene ERG: a key factor in prostate cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Barbieri, C. E., Baca, S. C., Lawrence, M. S., Demichelis, F., Blattner, M., Theurillat, J.-P., White, T. A., Stojanov, P., Van Allen, E., Stransky, N., et al. (2012) · Nature Genetics · doi:10.1038/ng.2279 · Cited by 1,558
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
The genomic complexity of primary human prostate cancer
Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,234
Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02232-10 · Cited by 1,108
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
Taichman, R. S., Cooper, C. R., Keller, E. T., Pienta, K. J., Taichman, N. S., & McCauley, L. K. (2002) · PubMed · Cited by 994
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Yu, J., Yu, J., Mani, R.-S., Cao, Q., Brenner, C. J., Cao, X., Wang, X., Wu, L., Li, J., Hu, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.018 · Cited by 850
Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., & Nelson, W. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11733 · Cited by 838
Sorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
Tomlins, S. A., Laxman, B., Varambally, S., Cao, X., Yu, J., Helgeson, B. E., Cao, Q., Prensner, J. R., Rubin, M. A., Shah, R. B., et al. (2008) · Neoplasia · doi:10.1593/neo.07822 · Cited by 690
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Carver, B. S., Tran, J., Gopalan, A., Chen, Z., Shaikh, S., Carracedo, A., Alimonti, A., Nardella, C., Varmeh, S., Scardino, P. T., et al. (2009) · Nature Genetics · doi:10.1038/ng.370 · Cited by 659
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J.-M., Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 645
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
Haffner, M. C., Aryee, M. J., Toubaji, A., Esopi, D. M., Albadine, R., Gurel, B., Isaacs, W. B., Bova, G. S., Liu, W., Xu, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.613 · Cited by 608
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568
Identification of a Cell of Origin for Human Prostate Cancer
Goldstein, A. S., Huang, J., Guo, C., Garraway, I. P., & Witte, O. N. (2010) · Science · doi:10.1126/science.1189992 · Cited by 554
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2.
Lin, B., Ferguson, C., White, J. T., Wang, S., Vessella, R. L., True, L. D., Hood, L., & Nelson, P. S. (1999) · PubMed · Cited by 531
TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
Perner, S., Demichelis, F., Beroukhim, R., Schmidt, F. H., Mosquera, J.-M., Setlur, S., Tchinda, J., Tomlins, S. A., Hofer, M. D., Pienta, K. G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1482 · Cited by 502
The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.
Karim, F. D., Urness, L. D., Thummel, C. S., Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., Maki, R. A., Gunther, C. V., & Nye, J. A. (1990) · Genes & Development · doi:10.1101/gad.4.9.1451 · Cited by 499
A putative second cell-derived oncogene of the avian leukaemia retrovirus E26
Leprince, D., Gegonne, A., Coll, J., de Taisne, C., Schneeberger, A., Lagrou, C., & Stehelin, D. (1983) · Nature · doi:10.1038/306395a0 · Cited by 459
Jolma, A., Kivioja, T., Toivonen, J., Cheng, L., Wei, G., Enge, M., Taipale, M., Vaquerizas, J. M., Yan, J., Sillanpää, M. J., et al. (2010) · Genome Research · doi:10.1101/gr.100552.109 · Cited by 441
Tripartite structure of the avian erythroblastosis virus E26 transforming gene
Nunn, M. F., Seeburg, P. H., Moscovici, C., & Duesberg, P. H. (1983) · Nature · doi:10.1038/306391a0 · Cited by 423
Brenner, J. C., Ateeq, B., Li, Y., Yocum, A. K., Cao, Q., Asangani, I. A., Patel, S., Wang, X., Liang, H., Yu, J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.010 · Cited by 415
Wang, J., Cai, Y., Ren, C., & Ittmann, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1966 · Cited by 404
Bertram, S., Heurich, A., Lavender, H., Gierer, S., Danisch, S., Perin, P., Lucas, J. M., Nelson, P. S., Pöhlmann, S., & Soilleux, E. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035876 · Cited by 398
Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer
Mani, R.-S., Tomlins, S. A., Callahan, K., Ghosh, A., Nyati, M. K., Varambally, S., Palanisamy, N., & Chinnaiyan, A. M. (2009) · Science · doi:10.1126/science.1178124 · Cited by 391
Ets target genes: past, present and future
Sementchenko, V. I., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204034 · Cited by 371
Nye, J. A., Petersen, J. M., Gunther, C. V., Jonsen, M. D., & Graves, B. J. (1992) · Genes & Development · doi:10.1101/gad.6.6.975 · Cited by 363
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
Petrovics, G., Liu, A., Shaheduzzaman, S., Furasato, B., Sun, C., Chen, Y., Nau, M., Ravindranath, L., Chen, Y., Dobi, A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208518 · Cited by 343
Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer
Setlur, S. R., Mertz, K. D., Hoshida, Y., Demichelis, F., Lupien, M., Perner, S., Sboner, A., Pawitan, Y., Andrén, O., Johnson, L. A., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn150 · Cited by 328
Pettersson, A., Graff, R. E., Bauer, S. R., Pitt, M. J., Lis, R. T., Stack, E. C., Martin, N. E., Kunz, L., Penney, K. L., Ligon, A. H., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0042 · Cited by 319
Common Gene Rearrangements in Prostate Cancer
Rubin, M. A., Maher, C. A., & Chinnaiyan, A. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.1916 · Cited by 307
Vanaja, D. K., Cheville, J. C., Iturria, S., & Young, C. Y. F. (2003) · PubMed · Cited by 305
Mehra, R., Tomlins, S. A., Shen, R., Nadeem, O., Wang, L., Wei, J. T., Pienta, K. J., Ghosh, D., Rubin, M. A., Chinnaiyan, A. M., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800769 · Cited by 303
A causal role for ERG in neoplastic transformation of prostate epithelium
Klezovitch, O., Risk, M., Coleman, I., Lucas, J. M., Null, M., True, L. D., Nelson, P. S., & Vasioukhin, V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711711105 · Cited by 302
The Structure of GABPα/β: An ETS Domain- Ankyrin Repeat Heterodimer Bound to DNA
Batchelor, A. H., Piper, D. E., de la Brousse, F. C., McKnight, S. L., & Wolberger, C. (1998) · Science · doi:10.1126/science.279.5353.1037 · Cited by 291
Hollenhorst, P. C., Shah, A. A., Hopkins, C., & Graves, B. J. (2007) · Genes & Development · doi:10.1101/gad.1561707 · Cited by 290
Gupta, S., Iljin, K., Sara, H., Mpindi, J. P., Mirtti, T., Vainio, P., Rantala, J., Alanen, K., Nees, M., & Kallioniemi, O. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0244 · Cited by 278
Basal epithelial stem cells are efficient targets for prostate cancer initiation
Lawson, D. A., Zong, Y., Memarzadeh, S., Xin, L., Huang, J., & Witte, O. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913873107 · Cited by 275
Yang, L., Xia, L., Wu, D. Y., Wang, H., Chansky, H. A., Schubach, W. H., Hickstein, D. D., & Zhang, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1204998 · Cited by 273
Loughran, S. J., Kruse, E. A., Hacking, D. F., de Graaf, C. A., Hyland, C. D., Willson, T. A., Henley, K. J., Ellis, S., Voss, A. K., Metcalf, D., et al. (2008) · Nature Immunology · doi:10.1038/ni.1617 · Cited by 269
Characterization of TMPRSS2 -ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
Mehra, R., Tomlins, S. A., Yu, J., Cao, X., Wang, L., Menon, A., Rubin, M. A., Pienta, K. J., Shah, R. B., & Chinnaiyan, A. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6154 · Cited by 269
Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin
Birdsey, G. M., Dryden, N. H., Amsellem, V., Gebhardt, F., Sahnan, K., Haskard, D. O., Dejana, E., Mason, J. C., & Randi, A. M. (2008) · Blood · doi:10.1182/blood-2007-08-105346 · Cited by 268
Birdsey, G. M., Shah, A. V., Dufton, N., Reynolds, L. E., Osuna Almagro, L., Yang, Y., Aspalter, I. M., Khan, S. T., Mason, J. C., Dejana, E., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2014.11.016 · Cited by 267
Emerging roles of ADAM and ADAMTS metalloproteinases in cancer
Rocks, N., Paulissen, G., El Hour, M., Quesada, F., Crahay, C., Gueders, M., Foidart, J. M., Noel, A., & Cataldo, D. (2008) · Biochimie · doi:10.1016/j.biochi.2007.08.008 · Cited by 266
Paoloni-Giacobino, A., Chen, H., Peitsch, M. C., Rossier, C., & Antonarakis, S. E. (1997) · Genomics · doi:10.1006/geno.1997.4845 · Cited by 264
SAM domains: uniform structure, diversity of function
Kim, C. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.11.001 · Cited by 259
Anderson, M. K., Hernandez-Hoyos, G., Diamond, R. A., & Rothenberg, E. V. (1999) · Development · doi:10.1242/dev.126.14.3131 · Cited by 258
Cerveira, N., Ribeiro, F. R., Peixoto, A., Costa, V., Henrique, R., Jerönimo, C., & Teixeira, M. R. (2006) · Neoplasia · doi:10.1593/neo.06427 · Cited by 258
Nam, R. K., Sugar, L., Yang, W., Srivastava, S., Klotz, L. H., Yang, L.-Y., Stanimirovic, A., Encioiu, E., Neill, M., Loblaw, D. A., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604054 · Cited by 257
Ichikawa, H., Shimizu, K., Hayashi, Y., & Ohki, M. (1994) · PubMed · Cited by 255
Sun, C., Dobi, A., Mohamed, A., Li, H., Thangapazham, R. L., Furusato, B., Shaheduzzaman, S., Tan, S.-H., Vaidyanathan, G., Whitman, E., et al. (2008) · Oncogene · doi:10.1038/onc.2008.183 · Cited by 253
Yuan, P., Han, J., Guo, G., Orlov, Y. L., Huss, M., Loh, Y.-H., Yaw, L.-P., Robson, P., Lim, B., & Ng, H.-H. (2009) · Genes & Development · doi:10.1101/gad.1831909 · Cited by 253
Regulation of the Epithelial Sodium Channel by Serine Proteases in Human Airways
Donaldson, S. H., Hirsh, A., Li, D. C., Holloway, G., Chao, J., Boucher, R. C., & Gabriel, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105044200 · Cited by 247
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Gopalan, A., Leversha, M. A., Satagopan, J. M., Zhou, Q., Al-Ahmadie, H. A., Fine, S. W., Eastham, J. A., Scardino, P. T., Scher, H. I., Tickoo, S. K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2467 · Cited by 246
TMPRSS2 : ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
Saramäki, O. R., Harjula, A. E., Martikainen, P. M., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2051 · Cited by 243
Iljin, K., Wolf, M., Edgren, H., Gupta, S., Kilpinen, S., Skotheim, R. I., Peltola, M., Smit, F., Verhaegh, G., Schalken, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1986 · Cited by 241
Hermans, K. G., van Marion, R., van Dekken, H., Jenster, G., van Weerden, W. M., & Trapman, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1871 · Cited by 240
Noninvasive Detection of TMPRSS2:ERG Fusion Transcripts in the Urine of Men with Prostate Cancer
Laxman, B., Tomlins, S. A., Mehra, R., Morris, D. S., Wang, L., Helgeson, B. E., Shah, R. B., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M. (2006) · Neoplasia · doi:10.1593/neo.06625 · Cited by 239
Furusato, B., Tan, S.-H., Young, D., Dobi, A., Sun, C., Mohamed, A. A., Thangapazham, R., Chen, Y., McMaster, G., Sreenath, T., et al. (2010) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2010.23 · Cited by 236
Mammalian ets-1 and ets-2 genes encode highly conserved proteins.
Watson, D. K., McWilliams, M. J., Lapis, P., Lautenberger, J. A., Schweinfest, C. W., & Papas, T. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7862 · Cited by 233
Myc confers androgen-independent prostate cancer cell growth
Bernard, D., Pourtier, A., Gil, J., & Beach, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19035 · Cited by 224
Expression and function of Ets transcription factors in mammalian development: a regulatory network
Maroulakou, I. G., & Bowe, D. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204039 · Cited by 221
Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease
Kim, T. S., Heinlein, C., Hackman, R. C., & Nelson, P. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.965-975.2006 · Cited by 217
Mosquera, J.-M., Perner, S., Genega, E. M., Sanda, M., Hofer, M. D., Mertz, K. D., Paris, P. L., Simko, J., Bismar, T. A., Ayala, G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5194 · Cited by 215
Mehra, R., Han, B., Tomlins, S. A., Wang, L., Menon, A., Wasco, M. J., Shen, R., Montie, J. E., Chinnaiyan, A. M., & Shah, R. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2043 · Cited by 214
Review of Ets1 structure, function, and roles in immunity
Garrett-Sinha, L. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1243-7 · Cited by 213
Böttcher-Friebertshäuser, E., Freuer, C., Sielaff, F., Schmidt, S., Eickmann, M., Uhlendorff, J., Steinmetzer, T., Klenk, H.-D., & Garten, W. (2010) · Journal of Virology · doi:10.1128/jvi.00140-10 · Cited by 211
TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells
Bertram, S., Glowacka, I., Blazejewska, P., Soilleux, E., Allen, P., Danisch, S., Steffen, I., Choi, S.-Y., Park, Y., Schneider, H., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00239-10 · Cited by 205
Zong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203
Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
Hatesuer, B., Bertram, S., Mehnert, N., Bahgat, M. M., Nelson, P. S., Pöhlman, S., & Schughart, K. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003774 · Cited by 198
An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors
Seidel, J. J., & Graves, B. J. (2002) · Genes & Development · doi:10.1101/gad.950902 · Cited by 182
The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells
WILSON, S., GREER, B., HOOPER, J., ZIJLSTRA, A., WALKER, B., QUIGLEY, J., & HAWTHORNE, S. (2005) · Biochemical Journal · doi:10.1042/bj20041066 · Cited by 178
Rao, V. N., Papas, T. S., & Reddy, E. S. P. (1987) · Science · doi:10.1126/science.3299708 · Cited by 176
Rajput, A. B., Miller, M. A., De Luca, A., Boyd, N., Leung, S., Hurtado-Coll, A., Fazli, L., Jones, E. C., Palmer, J. B., Gleave, M. E., et al. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.043810 · Cited by 175
Watson, D. K., McWilliams-Smith, M. J., Nunn, M. F., Duesberg, P. H., O'Brien, S. J., & Papas, T. S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7294 · Cited by 174
Chen, Y.-W., Lee, M.-S., Lucht, A., Chou, F.-P., Huang, W., Havighurst, T. C., Kim, K., Wang, J.-K., Antalis, T. M., Johnson, M. D., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090665 · Cited by 174
Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
Wang, J., Cai, Y., Yu, W., Ren, C., Spencer, D. M., & Ittmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1147 · Cited by 173
Larroux, C., Fahey, B., Liubicich, D., Hinman, V. F., Gauthier, M., Gongora, M., Green, K., Wörheide, G., Leys, S. P., & Degnan, B. M. (2006) · Evolution & Development · doi:10.1111/j.1525-142x.2006.00086.x · Cited by 173
Wright, M. E., Tsai, M.-J., & Aebersold, R. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0031 · Cited by 166
Evolutionarily conserved Ets family members display distinct DNA binding specificities.
Wang, C. Y., Petryniak, B., Ho, I. C., Thompson, C. B., & Leiden, J. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1391 · Cited by 162
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
Hawksworth, D., Ravindranath, L., Chen, Y., Furusato, B., Sesterhenn, I. A., McLeod, D. G., Srivastava, S., & Petrovics, G. (2010) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2010.31 · Cited by 162
Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif.
Donaldson, L. W., Petersen, J. M., Graves, B. J., & McIntosh, L. P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00340.x · Cited by 161
The erg gene: a human gene related to the ets oncogene.
Reddy, E. S., Rao, V. N., & Papas, T. S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6131 · Cited by 161
Berezovska, O. P., Glinskii, A. B., Yang, Z., Li, X., Hoffman, R. M., & Glinsky, G. V. (2006) · Cell Cycle · doi:10.4161/cc.5.16.3222 · Cited by 159
A transcriptional repressor co‐regulatory network governing androgen response in prostate cancers
Chng, K. R., Chang, C. W., Tan, S. K., Yang, C., Hong, S. Z., Sng, N. Y. W., & Cheung, E. C. W. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.112 · Cited by 159
Kanei-Ishii, C., Sarai, A., Sawazaki, T., Nakagoshi, H., He, D. N., Ogata, K., Nishimura, Y., & Ishii, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45472-x · Cited by 158
Complex patterns of ETS gene alteration arise during cancer development in the human prostate
Clark, J., Attard, G., Jhavar, S. G., Flohr, P., Reid, A. H. M., Bono, J. S. D., Eeles, R. A., Scardino, P. T., Cuzick, J. M., Fisher, G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210843 · Cited by 156
Brase, J. C., Johannes, M., Mannsperger, H., Fälth, M., Metzger, J., Kacprzyk, L. A., Andrasiuk, T., Gade, S., Meister, M. A., Sirma, H., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-507 · Cited by 156
Role of tryptophan repeats and flanking amino acids in Myb-DNA interactions.
Saikumar, P., Murali, R., & Reddy, E. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8452 · Cited by 152
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT
Kao, C.-J., Martiniez, A., Shi, X.-B., Yang, J. C., Evans, C. P., Dobi, A., White, R. D., & Kung, H.-J. (2013) · Oncogene · doi:10.1038/onc.2013.200 · Cited by 149
Shimizu, K., Ichikawa, H., Tojo, A., Kaneko, Y., Maseki, N., Hayashi, Y., Ohira, M., Asano, S., & Ohki, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10280 · Cited by 149
ETS transcription factors in endocrine systems
Gutierrez‐Hartmann, A., Duval, D. L., & Bradford, A. P. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.03.002 · Cited by 148
Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site
Slupsky, C. M., Gentile, L. N., Donaldson, L. W., Mackereth, C. D., Seidel, J. J., Graves, B. J., & McIntosh, L. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12129 · Cited by 148
Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer
Furusato, B., Gao, C., Ravindranath, L., Chen, Y., Cullen, J. C., McLeod, D. G., Dobi, A. L., Srivastava, S. K., Petrovics, G., & Sesterhenn, I. A. (2007) · Modern Pathology · doi:10.1038/modpathol.3800981 · Cited by 144
Abate-Shen, C. T., Shen, M. M., & Gelmann, E. P. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00292.x · Cited by 144
Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
Leinonen, K. A., Saramäki, O. R., Furusato, B., Kimura, T., Takahashi, H., Egawa, S., Suzuki, H., Keiger, K., Hahm, S. H., Isaacs, W. B., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0333-t · Cited by 144
Oncogene-mediated alterations in chromatin conformation
Rickman, D. S., Soong, T. D., Moss, B. J., Mosquera, J. M., Dlabal, J., Terry, S., MacDonald, T. Y., Tripodi, J., Bunting, K. L., Najfeld, V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112570109 · Cited by 143
Butticè, G., Duterque‐Coquillaud, M., Basuyaux, J. P., Carrère‐Kremer, S., Kurkinen, M., & Stéhelin, D. (1996) · PubMed · Cited by 140
The Proto-Oncogene ERG in Megakaryoblastic Leukemias
Rainis, L., Toki, T., Pimanda, J. E., Rosenthal, E., Machol, K., Strehl, S., Göttgens, B., Ito, E., & Izraeli, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0147 · Cited by 137
Lapointe, J., Kim, Y. H., Miller, M. A., Li, C., Kaygusuz, G., van de Rijn, M., Huntsman, D. D., Brooks, J. D., & Pollack, J. R. (2007) · Modern Pathology · doi:10.1038/modpathol.3800759 · Cited by 134
Iwamoto, M., Tamamura, Y., Koyama, E., Komori, T., Takeshita, N., Williams, J. A., Nakamura, T., Enomoto‐Iwamoto, M., & Pacifici, M. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.01.037 · Cited by 130
TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
Hägglöf, C., Hammarsten, P., Strömvall, K., Egevad, L., Josefsson, A., Stattin, P. E., Granfors, T., & Bergh, A. R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086824 · Cited by 130
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer
Wang, S., Kollipara, R. K., Srivastava, N., Li, R., Ravindranathan, P., Hernández, E., Freeman, E., Humphries, C. G., Kapur, P., Lotan, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322198111 · Cited by 130
Leshem, O., Madar, S., Kogan-Sakin, I., Kamer, I., Goldstein, I., Brosh, R., Cohen, Y., Jacob‐Hirsch, J., Ehrlich, M., Ben‐Sasson, S. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021650 · Cited by 126
Werner, M. H., Clore, G. M., Fisher, C. L., Fisher, R. J., Trinh, L. B., Shiloach, J., & Gronenborn, A. M. (1995) · Cell · doi:10.1016/0092-8674(95)90189-2 · Cited by 126
Yeap, L.-S., Hayashi, K., & Surani, M. A. (2009) · Epigenetics & Chromatin · doi:10.1186/1756-8935-2-12 · Cited by 126
Yang, L., Mei, Q., Zielinska‐Kwiatkowska, A., Matsui, Y., Blackburn, M. L., Benedetti, D. J., Krumm, A., Taborsky, G. J., & Chansky, H. A. (2003) · Biochemical Journal · doi:10.1042/bj20020854 · Cited by 125
Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22)
Panagopoulos, I., Åman, P., Fioretos, T., Höglund, M., Johansson, B., Mandahl, N., Heim, S., Behrendtz, M., & Mitelman, F. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110408 · Cited by 125
ERG Is a Megakaryocytic Oncogene
Salek‐Ardakani, S., Smooha, G., de Boer, J., Sebire, N. J., Morrow, M., Rainis, L., Lee, S., Williams, O., Izraeli, S., & Brady, H. J. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0075 · Cited by 125
Chatterjee, P., Choudhary, G. S., Sharma, A., Singh, K., Heston, W. D. W., Ciezki, J. P., Klein, E. A., & Almasan, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060408 · Cited by 122
Winnes, M., Lissbrant, E., Damber, J., et al. (2007) · Oncology Reports · doi:10.3892/or.17.5.1033 · Cited by 117
ETS rearrangements and prostate cancer initiation
Carver, B. S., Tran, J., Chen, Z., Carracedo, A., Alimonti, A., Nardella, C., Gopalan, A., Scardino, P. T., Cordon‐Cardo, C., Gerald, W. L., et al. (2009) · Nature · doi:10.1038/nature07738 · Cited by 114
Basuyaux, J. P., Ferreira, E., Stéhelin, D., & Butticè, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26188 · Cited by 113
YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion
Rahim, S., Beauchamp, E. M., Kong, Y., Brown, M. L., Toretsky, J. A., & Üren, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019343 · Cited by 113
Baldus, C. D., Burmeister, T., Martus, P., Schwartz, S., Gökbuget, N., Bloomfield, C. D., Hoelzer, D. F., Thiel, E., & Hofmann, W. K. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1580 · Cited by 110
Ets Proteins: New Factors That Regulate Immunoglobulin Heavy-Chain Gene Expression
Rivera, R. R., Stuiver, M. H., Steenbergen, R. D. M., & Murre, C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7163 · Cited by 107
Seth, A. K., Ascione, R., Fisher, R. J., Mavrothalassitis, G., BHAT, N. K., & Papas, T. S. (1992) · Cell growth & differentiation · Cited by 106
Carrère‐Kremer, S., Verger, A., Flourens, A., Stéhelin, D., & Duterque‐Coquillaud, M. (1998) · Oncogene · doi:10.1038/sj.onc.1201868 · Cited by 106
Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells
Bastus, N. C., Boyd, L. K., Mao, X., Stankiewicz, E., Kudahetti, S. C., Oliver, R. T. D., Berney, D. M., & Lu, Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1638 · Cited by 105
Solution structure of the ets domain of Fli-1 when bound to DNA
Liang, H., Mao, X., Olejniczak, E. T., Nettesheim, D. G., Yu, L., Meadows, R. P., Thompson, C. B., & Fesik, S. W. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb1294-871 · Cited by 104
Thoms, J. A. I., Birger, Y., Foster, S., Knezevic, K., Kirschenbaum, Y., Chandrakanthan, V., von Jonquières, G., Spensberger, D., Wong, J. W. H., Oram, S. H., et al. (2011) · Blood · doi:10.1182/blood-2010-12-317990 · Cited by 104
Boulukos, K. E., Pognonec, P., Rabault, B., Begue, A., & Ghysdael, J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.12.5718-5721.1989 · Cited by 103
Fine, S. W., Gopalan, A., Leversha, M. A., Al‐Ahmadie, H. A., Tickoo, S. K., Zhou, Q. C., Satagopan, J. M., Scardino, P. T., Gerald, W. L., & Reuter, V. E. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.120 · Cited by 103
Yuan, L., Bras, A. L., Sacharidou, A., Itagaki, K., Zhan, Y., Kondo, M., Carman, C. V., Davis, G. E., Aird, W. C., & Oettgen, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.300236 · Cited by 103
McLaughlin, F., Ludbrook, V. J., Cox, J. M., von Carlowitz, I., Brown, S., & RANDI, A. M. (2001) · Blood · doi:10.1182/blood.v98.12.3332 · Cited by 103
Regulation of endothelial cell development by ETS transcription factors
Meadows, S. M., Myers, C. T., & Krieg, P. A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.009 · Cited by 101
Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer
Hu, Y., Dobi, A., Sreenath, T., Cook, C., Tadase, A. Y., Ravindranath, L., Cullen, J. C., Furusato, B., Chen, Y., Thangapazham, R. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0531 · Cited by 99
ERG Is a Critical Regulator of Wnt/LEF1 Signaling in Prostate Cancer
Wu, L., Zhao, J. C., Kim, J., Jin, H., Wang, C.-Y., & Yu, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0882 · Cited by 97
Heo, S., Choi, Y., Ryoo, H., & Cho, J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22175 · Cited by 95
Xiao, J., Gong, A., Eischeid, A. N., Chen, D., Deng, C., Young, C. Y. F., & Chen, X. (2012) · The Prostate · doi:10.1002/pros.22501 · Cited by 93
Birdsey, G. M., Dryden, N. H., Shah, A. V., Hannah, R., Hall, M. D., Haskard, D. O., Parsons, M., Mason, J. C., Zvelebil, M., Göttgens, B., et al. (2011) · Blood · doi:10.1182/blood-2011-04-350025 · Cited by 93
Hermans, K. G., Boormans, J. L., Tandefelt, D. G., van Leenders, G. J. L. H., Jenster, G. W., Verhagen, P. C. M. S., & Trapman, J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1176 · Cited by 93
Determinants of DNA-Binding Specificity of ETS-Domain Transcription Factors
Shore, P., Whitmarsh, A. J., Bhaskaran, R., Davis, R. J., Waltho, J. P., & Sharrocks, A. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3338 · Cited by 92
Tian, T. V., Tomavo, N., Huot, L., Flourens, A., Bonnelye, E., Flajollet, S., Hot, D., Leroy, X., de Launoit, Y., & Duterque‐Coquillaud, M. (2013) · Oncogene · doi:10.1038/onc.2013.176 · Cited by 92
Dhordain, P., Dewitte, F., Desbiens, X., Stéhelin, D., & Duterque‐Coquillaud, M. (1995) · Mechanisms of Development · doi:10.1016/0925-4773(94)00322-e · Cited by 91
Promotion and maintenance of leukemia by ERG
Tsuzuki, S., Taguchi, O., & Seto, M. (2011) · Blood · doi:10.1182/blood-2010-11-320515 · Cited by 88
Vlaeminck‐Guillem, V., Carrère‐Kremer, S., Dewitte, F., Stéhelin, D., Desbiens, X., & Duterque‐Coquillaud, M. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00272-5 · Cited by 88
The ETS-domain transcription factors Elk-1 and SAP-1 exhibit differential DNA binding specifitoies
Shore, P., & Sharrocks, A. D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.22.4698 · Cited by 83
PTEN loss induces epithelial--mesenchymal transition in human colon cancer cells.
Bowen, K. A., Doan, H. Q., Zhou, B. P., Wang, Q., Zhou, Y., Rychahou, P. G., & Evers, B. M. (2009) · PubMed · Cited by 83
Yuan, L., Sacharidou, A., Stratman, A. N., Bras, A. L., Zwiers, P. J., Spokes, K., Bhasin, M., Shih, S., Nagy, J. A., Molema, G., et al. (2011) · Blood · doi:10.1182/blood-2010-10-315275 · Cited by 82
Nhili, R., Peixoto, P., Depauw, S., Flajollet, S., Dezitter, X., Munde, M. M., Ismail, M. A., Kumar, A., Farahat, A. A., Stephens, C. E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks971 · Cited by 79
Vijayaraj, P., Bras, A. L., Mitchell, N. J., Kondo, M., Juliao, S. F., Wasserman, M. C., Beeler, D. L., Spokes, K., Aird, W. C., Baldwin, H. S., et al. (2012) · Development · doi:10.1242/dev.081596 · Cited by 78
Iwamoto, M., Higuchi, Y., Koyama, E., Enomoto‐Iwamoto, M., Kurisu, K., Yeh, H., Abrams, W. R., Rosenbloom, J., & Pacifici, M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.1.27 · Cited by 78
Björkman, M. L., Iljin, K., Halonen, P., Sara, H., Kaivanto, E., Nees, M., & Kallioniemi, O. (2008) · International Journal of Cancer · doi:10.1002/ijc.23885 · Cited by 73
Anton, I. A., & Frampton, J. (1988) · Nature · doi:10.1038/336719a0 · Cited by 71
ETS-dependent regulation of a distal Gata4 cardiac enhancer
Schachterle, W., Rojas, A., Xu, S.-M., & Black, B. L. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.10.023 · Cited by 71
DNA Binding by the ETS Protein TEL (ETV6) Is Regulated by Autoinhibition and Self-association
Green, S. M., Coyne, H. J., McIntosh, L. P., & Graves, B. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.096958 · Cited by 69
Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice
Ng, A. P., Loughran, S. J., Metcalf, D., Hyland, C. D., de Graaf, C. A., Hu, Y., Smyth, G. K., Hilton, D. J., Kile, B. T., & Alexander, W. S. (2011) · Blood · doi:10.1182/blood-2011-03-344739 · Cited by 69
Cooperative DNA Binding with AP-1 Proteins Is Required for Transformation by EWS-Ets Fusion Proteins
Kim, S., Denny, C. T., & Wisdom, R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2467-2478.2006 · Cited by 68
Diversity in Structure and Function of the Ets Family PNT Domains
Mackereth, C. D., Schärpf, M., Gentile, L. N., MacIntosh, S. E., Slupsky, C. M., & McIntosh, L. P. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.094 · Cited by 67
Reddy, E. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1014 · Cited by 67
Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models
Becker‐Santos, D. D., Guo, Y., Ghaffari, M., Vickers, E. D., Lehman, M., Altamirano-Dimas, M., Oloumi, A., Furukawa, J., Sharma, M., Wang, Y. Z., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs285 · Cited by 66
The proto‐oncogene ERG is a target of micro RNA miR‐145in prostate cancer
Hart, M., Wach, S., Nolte, E., Szczyrba, J., Menon, R., Taubert, H. W., Hartmann, A., Stoehr, R., Wieland, W. F., Grässer, F. A., et al. (2013) · FEBS Journal · doi:10.1111/febs.12236 · Cited by 64
Zhang, X., Fournier, M. V., Ware, J. L., Bissell, M. J., Yacoub, A., & Zehner, Z. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0544 · Cited by 63
Rickman, D. S., Chen, Y.-B., Banerjee, S., Pan, Y., Yu, J., Vuong, T., Perner, S., Lafargue, C. J., Mertz, K. D., Setlur, S. R., et al. (2010) · Neoplasia · doi:10.1593/neo.10866 · Cited by 62
Androgen receptor-driven chromatin looping in prostate cancer
Wu, D., Zhang, C., Shen, Y., Nephew, K. P., & Wang, Q. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.07.006 · Cited by 62
Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene Using Liposomal Nanovectors
Shao, L., Tekedereli, İ., Wang, J., Yuca, E., Tsang, S. V., Sood, A. K., Lopez‐Berestein, G., Özpolat, B., & Ittmann, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2715 · Cited by 62
Cai, J., Kandagatla, P., Singareddy, R., Kropinski, A., Sheng, S., Cher, M. L., & Chinni, S. R. (2010) · Translational Oncology · doi:10.1593/tlo.09328 · Cited by 61
ERG is required for the differentiation of embryonic stem cells along the endothelial lineage
Nikolova-Krstevski, V., Yuan, L., Bras, A. L., Vijayaraj, P., Kondo, M., Gebauer, I., Bhasin, M., Carman, C. V., & Oettgen, P. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-72 · Cited by 61
ERG gene is translocated in an Ewing's sarcoma cell line
Dunn, T., Praissman, L. A., Hagag, N. G., & Viola, M. V. (1994) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)90063-9 · Cited by 60
erg, an ets-related gene, codes for sequence-specific transcriptional activators.
Reddy, E. S. P., & Rao, V. N. (1991) · PubMed · Cited by 60
Lathen, C., Zhang, Y., Chow, J., Singh, M., Lin, G., Nigam, V., Ashraf, Y. A., Yuan, J. X. ‐., Robbins, I. M., & Thistlethwaite, P. A. (2014) · Circulation · doi:10.1161/circulationaha.113.007822 · Cited by 59
Oncogenic activation of ERG: A predominant mechanism in prostate cancer
Srivastava, S., Sreenath, T., Dobi, A., & Petrovics, G. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.91122 · Cited by 59
Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis
Robert, G., Jannink, S. A., Smit, F. P., Aalders, T. W., Hessels, D., Cremers, R. G. H. M., Mulders, P., & Schalken, J. A. (2012) · The Prostate · doi:10.1002/pros.22546 · Cited by 56
Tsourlakis, M., Weigand, P., Grupp, K., Kluth, M., Steurer, S. A., Schlomm, T., Graefen, M., Huland, H., Salomon, G., Steuber, T. P., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.007 · Cited by 55
Verger, A., Buisine, E., Carrère‐Kremer, S., Wintjens, R. T., Flourens, A., Coll, J., Stéhelin, D., & Duterque‐Coquillaud, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010208200 · Cited by 54
TMPRSS2–ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c
Kim, J., Wu, L., Zhao, J. C., Jin, H.-J., & Yu, J. (2013) · Oncogene · doi:10.1038/onc.2013.461 · Cited by 54
Regan, M. C., Horanyi, P. S., Pryor, E. E., Sarver, J. L., Cafiso, D. S., & Bushweller, J. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301726110 · Cited by 54
miR-221 Is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer.
Gordanpour, A., Stanimirovic, A., Nam, R. K., Moreno, C. S., Sherman, C., Sugar, L., & Seth, A. K. (2011) · PubMed · Cited by 52
Characterization of the DNA binding and transcriptional activation domains of the erg protein.
Siddique, H., Rao, V. N., Lee, L., & Reddy, E. S. (1993) · PubMed · Cited by 51
New human erg isoforms generated by alternative splicing are transcriptional activators.
Duterque‐Coquillaud, M., Niel, C., Plaza, S., & Stéhelin, D. (1993) · PubMed · Cited by 51
TMPRSS2–ERG-Mediated Feed-Forward Regulation of Wild-Type ERG in Human Prostate Cancers
Mani, R. S., Iyer, M. K., Cao, Q., Brenner, J. C., Wang, L., Ghosh, A., Cao, X., Lonigro, R. J., Tomlins, S. A., Varambally, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0876 · Cited by 51
Human ERG is a proto-oncogene with mitogenic and transforming activity.
Hart, A. H., Corrick, C. M., Tymms, M. J., Hertzog, P. J., & Kola, I. (1995) · PubMed · Cited by 51
Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer
Rubin, M. A., & Chinnaiyan, A. M. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700477 · Cited by 50
Thangapazham, R. L., Sáenz, F., Katta, S., Mohamed, A. A. M., Tan, S., Petrovics, G., Srivastava, S. K., & Dobi, A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-16 · Cited by 47
Owczarek, C. M., Portbury, K. J., Hardy, M. P., O’Leary, D. A., Kudoh, J., Shibuya, K., Shimizu, N., Kola, I., & Hertzog, P. J. (2003) · Gene · doi:10.1016/j.gene.2003.09.047 · Cited by 47
Liu, W., Ewing, C. M., Chang, B., Li, T., Sun, J., Turner, A. R., Dimitrov, L. M., Zhu, Y., Sun, J., Kim, J. W., et al. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20482 · Cited by 46
5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer
Zammarchi, F., Boutsalis, G., & Cartegni, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0049721 · Cited by 46
Mohamed, A. A. M., Tan, S., Mikhalkevich, N., Ponniah, S., Vasioukhin, V. I., Bieberich, C. J., Sesterhenn, I. A., Dobi, A., Srivastava, S. K., & Sreenath, T. (2010) · Journal of Cancer · doi:10.7150/jca.1.197 · Cited by 46
Casey, O. M., Fang, L., Hynes, P. G., Abou-Kheir, W. G., Martin, P. L., Tillman, H. S., Petrovics, G., Awwad, H. O., Ward, Y., Lake, R. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041668 · Cited by 44
Transcriptional Regulation of CXCR4 in Prostate Cancer: Significance of TMPRSS2-ERG Fusions
Singareddy, R., Semaan, L., Conley‐LaComb, M. K., John, J. S., Powell, K., Iyer, M. K., Smith, D. W., Heilbrun, L. K., Shi, D., Sakr, W., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0705 · Cited by 44
Autoinhibition of ETV6 (TEL) DNA Binding: Appended Helices Sterically Block the ETS Domain
Coyne, H. J., De, S., Okon, M., Green, S. M., Bhachech, N., Graves, B. J., & McIntosh, L. P. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.05.010 · Cited by 41
Genomic dispersal of the ets gene family during metazoan evolution.
Lautenberger, J. A., Burdett, L. A., Gunnell, M., Qi, S., Watson, D. K., O’Brien, S. J., & Papas, T. S. (1992) · PubMed · Cited by 36
Camuzeaux, B., Spriet, C., Héliot, L., Coll, J., & Duterque‐Coquillaud, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.057 · Cited by 34
Bosco, A., Bureau, C., Affaticati, P., Gaspar, P., Bally‐Cuif, L., & Lillesaar, C. (2012) · Development · doi:10.1242/dev.089094 · Cited by 33
Shwartz, A., Yogev, S., Schejter, E. D., & Shilo, B. (2013) · Development · doi:10.1242/dev.093138 · Cited by 32
Erg cooperates with TGF-β to control mesenchymal differentiation
Cox, M. K., Appelboom, B., Ban, G. I., & Serra, R. A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.015 · Cited by 22
Differentially spliced erg-3 product functions as a transcriptional activator.
Dd, P., Rao, V. N., Lee, L., & Reddy, E. S. (1994) · PubMed · Cited by 22
Deramaudt, T. B., Rémy, P., & Stiegler, P. (2001) · Gene · doi:10.1016/s0378-1119(01)00610-2 · Cited by 21
Bohne, A., Schlee, C., Mossner, M., Thibaut, J., Heesch, S., Thiel, E., Hofmann, W., & Baldus, C. D. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.11.012 · Cited by 19
Schwartzman, J. A., Mongoue‐Tchokote, S., Gibbs, A., Gao, L., Corless, C. L., Jin, J. M., Zarour, L. R., Higano, C. S., True, L. D., Vessella, R. L., et al. (2011) · Epigenetics · doi:10.4161/epi.6.10.17727 · Cited by 17
Lau, D., Okon, M., & McIntosh, L. P. (2012) · Protein Science · doi:10.1002/pro.2151 · Cited by 9
Objective: tumor. Strategies of drug targeting at the tumor mass level
Martín‐Sabroso, C., & Torres‐Suárez, A. I. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1075-4 · Cited by 8
Detection of TMPRSS2-ERG fusion gene in benign prostatic hyperplasia
Velaeti, S., Dimitriadis, E., Kontogianni-Katsarou, K., Savvani, A., Sdrolia, E., Pantazi, G., Stefanakis, S., Trangas, T. T., Pandis, N., & Petraki, K. (2014) · Tumor Biology · doi:10.1007/s13277-014-2250-0 · Cited by 6
Cited by
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
Schram, A. M., Chang, M. T., Jonsson, P., & Drilon, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.127 · Cited by 323
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
He, Y., Xu, W., Xiao, Y.-T., Huang, H., Gu, D., & Ren, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01042-7 · Cited by 261
Kalna, V., Yang, Y., Peghaire, C. R., Frudd, K., Hannah, R., Shah, A. V., Osuna Almagro, L., Boyle, J. J., Göttgens, B., Ferrer, J., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313788 · Cited by 119
Zhao, W., Qin, P., Zhang, D., Cui, X., Gao, J., Yu, Z., Chai, Y., Wang, J., & Li, J. (2019) · Aging · doi:10.18632/aging.102406 · Cited by 115
Destruction of DNA-binding proteins by programmable O’PROTAC: Oligonucleotide-based PROTAC
Shao, J., Yan, Y., Ding, D., Wang, D., He, Y., Pan, Y., Yan, W., Kharbanda, A., Li, H.-Y., & Huang, H. (2021) · doi:10.1101/2021.03.08.434493 · Cited by 2
Metadata
- Authors
- Adamo, P., & Ladomery, M. R.
- Venue
- Oncogene
- Published
- 2015-04-27
- Volume
- 35
- Issue
- 4
- Pages
- 403-414
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2016571009
- Cited by
- 275
- References
- 197
- FWCI
- 13.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.